<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Cancer Biology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B9C85C8E-D020-4BB5-B5E4-A8A5AB28B9E3"><gtr:id>B9C85C8E-D020-4BB5-B5E4-A8A5AB28B9E3</gtr:id><gtr:firstName>Pablo</gtr:firstName><gtr:surname>Rodriguez-Viciana</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801150"><gtr:id>A8005C9A-1E9E-4E6F-9FAF-D8A196B2118E</gtr:id><gtr:title>R-Ras GTPases in the regulation of the Wnt Planar Cell Polarity pathway</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801150</gtr:grantReference><gtr:abstractText>The ability of cells to move to different parts of the body plays a critical role during development of the embryo and in many cellular processes after birth. Tumour cells can hijack this process and use it to spread and invade other organs.
The Planar Cell Polarity (PCP) pathway is a molecular process that controls the appropriate movement of cells. Abnormalities in this pathway cause a variety of diseases, including the two most common type of birth defects in humans: cardiac and neural tube defects (such as spina bifida).
R-Ras proteins regulate a variety of biological processes, including cell movement. We have found new links between R-Ras proteins and molecules involved in the PCP pathway. We plan to work out the precise mechanisms that are involved in this process and to test the overall importance of R-Ras in the normal functioning of the PCP pathway.
A better understanding of the interaction between these two pathways will help us understand how the complex process of cell movement is coordinated and may have implications for the detection and treatment of the numerous diseases where the R-Ras and PCP pathways are involved.</gtr:abstractText><gtr:technicalSummary>R-Ras GTPases, closely related members of the Ras oncogene family, regulate migration and adhesion through a poorly defined mechanism. The Wnt-Planar Cell Polarity (PCP) pathway is involved in directed cell motility by regulating Rho GTPases by an unknown mechanism. We have identified Vangl, a known component of the PCP pathway, and p164RhoGEF (a Rho activator) as novel effectors of R-Ras GTPases. We propose to investigate the hypothesis that R-Ras GTPases function downstream of Wnt ligands in the PCP pathway, coordinating the regulation of Vangl and p164RhoGEF to control cell polarity and motility through the activation of specific pools of Rho GTPases.</gtr:technicalSummary><gtr:fund><gtr:end>2012-02-08</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-02-09</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>497416</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5882E1E4-9452-4771-8E53-341A25614F95</gtr:id><gtr:title>An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a5edc72bdf28990a97362547ecea64c"><gtr:id>9a5edc72bdf28990a97362547ecea64c</gtr:id><gtr:otherNames>Young LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>me9UYrHhKhH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A15B8F42-506E-484C-A483-E4AF0F659C91</gtr:id><gtr:title>ERBB4 confers metastatic capacity in Ewing sarcoma.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3ec895a7ef070d67b5d05396d1c4041"><gtr:id>b3ec895a7ef070d67b5d05396d1c4041</gtr:id><gtr:otherNames>Mendoza-Naranjo A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>pm_15374_24_23681745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>265715D8-85CB-4FAE-BC98-5BFF1679A42A</gtr:id><gtr:title>VANGL1 links the RRAS subgroup of the RAS family to the non-canonical WNT signallng pathway</gtr:title><gtr:parentPublicationTitle>manuscript in preparation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4adf2342de256dfaaebf4c3eb0d116ee"><gtr:id>4adf2342de256dfaaebf4c3eb0d116ee</gtr:id><gtr:otherNames>Hartig, Nicole</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>QTRzDxERZbh</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801150</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>